NCT03847753 Exploring the Comorbidity Between Mental Disorders and General Medical Conditions Status COMPLETED Phase N/A
NCT03839251 Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia Patients Status COMPLETED Phase PHASE4
NCT03838484 Effects of Transdermal Nicotine on Response Inhibition to Emotional Cues in Schizophrenia Status TERMINATED Phase NA
NCT03837340 Community-based Mental Health Care for People With Severe and Enduring Mental Ill Health Status UNKNOWN Phase NA
NCT03829280 Cognitive Adaption Training-Effectiveness in Real-world Settings and Mechanism of Action (CAT-EM) Status COMPLETED Phase NA
NCT03829124 Comparison of Ketamine Combine Propofol vs Propofol Anesthesia in Schizophrenia Electroconvulsive Therapy Status UNKNOWN Phase PHASE4
NCT03820362 The Role of Personal Identity in Psychotic Symptoms: a Study With the Repertory Grid Technique Status COMPLETED Phase N/A
NCT03818516 Impact of Inflammation on Reward Circuits, Motivational Deficits and Negative Symptoms in Schizophrenia Status COMPLETED Phase NA
NCT03817502 Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia Status RECRUITING Phase PHASE3
NCT03810755 EfiKroniK Research Program: Physical Exercise for People With Chronic Pathologies Status COMPLETED Phase NA
NCT03809325 A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly Status COMPLETED Phase N/A
NCT03807388 ReMindCare App for Patients From First Episode of Psychosis Unit. Status UNKNOWN Phase NA
NCT03802838 Clinical Evaluation of Acupuncture Treatment for Negative Symptoms of Schizophrenia Status UNKNOWN Phase PHASE4
NCT03801551 Validation of a Tool for the Dimensional Assessment of Apathy in a Population Suffering From Schizophrenia. Status COMPLETED Phase NA
NCT03794076 Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia Status RECRUITING Phase PHASE1/PHASE2
NCT03793712 Study With Lu AF11167 for the Treatment of Negative Symptoms in Patients With Schizophrenia Status TERMINATED Phase PHASE2